GNLX logo

Genelux Corporation

GNLX
Healthcare|Biotechnology|US
$1.96
+0.14 (+7.69%)
Tangible Book / Share
$0.36
Cash / Share
$0.42

Ownership Breakdown

80.7%
Float
45.2M
Shares Outstanding
36.5M
Float Shares

Major Holders (3)

Combined: 26.2%

Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.

HolderType% of ClassSharesFiledFiling
Steven BoydHC, IN9.99%4,223,277Nov 14, 202513D/G
Armistice Capital, LLCIA, OO9.99%4,223,277Nov 14, 202513D/G
Aladar SzalayIndividual6.20%2,834,465Nov 4, 202613D/G

Insider Trades (100)

Last 4 quarters: 2,052,523 acquired · 105,606 disposed
InsiderPositionDateTypeSharesPriceValueFiling
Cappello JosephChief Technical OfficerNov 3, 2026SELL668$2.04$1.4KForm 4
Zindrick ThomasPresident and CEONov 3, 2026SELL3,089$2.05$6.3KForm 4
Yu YongChief Scientific OfficerNov 3, 2026SELL668$2.01$1.3KForm 4
Cappello JosephChief Technical OfficerAug 31, 2026SELL10,257$2.74$28.1KForm 4
Zindrick ThomasPresident and CEOAug 31, 2026SELL34,463$2.67$91.9KForm 4
Yu YongChief Scientific OfficerAug 31, 2026SELL9,683$2.75$26.7KForm 4
Yu YongChief Scientific OfficerAug 4, 2026SELL653$2.94$1.9KForm 4
Cappello JosephChief Technical OfficerAug 4, 2026SELL653$2.95$1.9KForm 4
Zindrick ThomasPresident and CEOAug 4, 2026SELL3,023$2.95$8.9KForm 4
Smither John WdirectorJul 1, 2026SELL12,000$2.91$34.9KForm 4
Pulisic MatthewChief Financial OfficerJun 16, 2026AWARD278,906——Form 4
Groen EricGeneral CounselJun 16, 2026AWARD233,957——Form 4
Cappello JosephChief Technical OfficerJun 16, 2026AWARD174,841——Form 4
Tyree James LdirectorJun 16, 2026AWARD28,409——Form 4
Tyree James LdirectorJun 16, 2026AWARD31,566$3.03$95.6KForm 4
Zindrick ThomasPresident and CEOJun 16, 2026AWARD730,601——Form 4
Thomas JohndirectorJun 16, 2026AWARD28,409——Form 4
Thomas JohndirectorJun 16, 2026AWARD31,566$3.03$95.6KForm 4
Mirabelli MarydirectorJun 16, 2026AWARD28,409——Form 4
Mirabelli MarydirectorJun 16, 2026AWARD31,566$3.03$95.6KForm 4
Yu YongChief Scientific OfficerJun 16, 2026AWARD119,318——Form 4
Smither John WdirectorJun 16, 2026AWARD28,409——Form 4
Smither John WdirectorJun 16, 2026AWARD31,566$3.03$95.6KForm 4
Smalling RalphHead of RegulatoryJun 3, 2026SELL192$2.93$562.56Form 4
Thomas JohndirectorJun 1, 2026SELL10,000$2.98$29.8KForm 4
Yu YongChief Scientific OfficerMay 11, 2026SELL605$2.97$1.8KForm 4
Cappello JosephChief Technical OfficerMay 11, 2026SELL605$2.97$1.8KForm 4
Zindrick ThomasPresident and CEOMay 11, 2026SELL2,798$2.94$8.2KForm 4
Smalling RalphHead of RegulatoryMay 11, 2026SELL270$2.98$804.49Form 4
Smalling RalphHead of RegulatoryMar 24, 2026SELL345$2.42$834.90Form 4
Smalling RalphHead of RegulatoryMar 25, 2026SELL240$2.51$602.40Form 4
Cappello JosephChief Technical OfficerMar 24, 2026SELL906$2.42$2.2KForm 4
Yu YongSVP, Clinical DevelopmentMar 24, 2026SELL906$2.42$2.2KForm 4
Zindrick ThomasPresident and CEOMar 24, 2026SELL3,582$2.42$8.7KForm 4
Thomas JohndirectorMar 2, 2026SELL10,000$2.90$29.0KForm 4
Litten JasonChief Medical OfficerJan 2, 2026AWARD275,000$4.55$1.3MForm 4
Litten JasonofficerJan 2, 2026OTHER0——Form 4
Yu YongSVP, Clinical DevelopmentAug 21, 2025SELL3,219$3.36$10.8KForm 4
Yu YongSVP, Clinical DevelopmentNov 17, 2025SELL973$5.37$5.2KForm 4
Zindrick ThomasPresident and CEOAug 21, 2025SELL12,673$3.33$42.2KForm 4
Zindrick ThomasPresident and CEONov 17, 2025SELL4,509$5.37$24.2KForm 4
Cappello JosephChief Technical OfficerAug 21, 2025SELL1,270$3.33$4.2KForm 4
Cappello JosephChief Technical OfficerAug 21, 2025SELL1,463$3.36$4.9KForm 4
Cappello JosephChief Technical OfficerNov 17, 2025SELL973$5.37$5.2KForm 4
Smalling RalphHead of RegulatoryAug 21, 2025SELL1,244$3.36$4.2KForm 4
Smalling RalphHead of RegulatorySep 3, 2025SELL580$3.36$1.9KForm 4
Smalling RalphHead of RegulatoryNov 17, 2025SELL343$5.37$1.8KForm 4
Smalling RalphHead of RegulatoryDec 5, 2025SELL165$4.69$773.85Form 4
Thomas JohndirectorDec 1, 2025SELL10,000$5.00$50.0KForm 4
Zindrick Thomasdirector, officer: President and CEOSep 1, 2025AWARD925,000$3.33$3.1MForm 4
Zindrick Thomasdirector, officer: President and CEOSep 1, 2025AWARD250,000$3.33$832.5KForm 4
Zindrick Thomasdirector, officer: President and CEOSep 1, 2025AWARD157,372$3.33$524.0KForm 4
Zindrick Thomasdirector, officer: President and CEOSep 1, 2025AWARD23,568$3.33$78.5KForm 4
Zindrick Thomasdirector, officer: President and CEOSep 1, 2025DISPOSED23,568$6.00$141.4KForm 4
Zindrick Thomasdirector, officer: President and CEOSep 1, 2025DISPOSED250,000$22.40$5.6MForm 4
Yu YongSVP, Clinical DevelopmentSep 1, 2025AWARD207,652$3.33$691.5KForm 4
Yu YongSVP, Clinical DevelopmentSep 1, 2025AWARD65,000$3.33$216.4KForm 4
Yu YongSVP, Clinical DevelopmentSep 1, 2025DISPOSED65,000$22.40$1.5MForm 4
Yu YongSVP, Clinical DevelopmentSep 1, 2025DISPOSED207,652$6.00$1.2MForm 4
Smalling RalphHead of RegulatorySep 1, 2025AWARD10,000——Form 4
Smalling RalphHead of RegulatorySep 1, 2025AWARD8,333$3.33$27.7KForm 4
Smalling RalphHead of RegulatorySep 1, 2025DISPOSED8,333$6.00$50.0KForm 4
Cappello JosephChief Technical OfficerSep 1, 2025AWARD80,000$3.33$266.4KForm 4
Cappello JosephChief Technical OfficerSep 1, 2025AWARD65,000$3.33$216.4KForm 4
Cappello JosephChief Technical OfficerSep 1, 2025AWARD16,666$3.33$55.5KForm 4
Cappello JosephChief Technical OfficerSep 1, 2025AWARD13,333$3.33$44.4KForm 4
Cappello JosephChief Technical OfficerSep 1, 2025DISPOSED65,000$22.40$1.5MForm 4
Cappello JosephChief Technical OfficerSep 1, 2025DISPOSED13,333$6.00$80.0KForm 4
Thomas JohndirectorAug 27, 2025AWARD22,283——Form 4
Thomas JohndirectorAug 27, 2025AWARD28,576$3.64$104.0KForm 4
Zindrick ThomasPresident and CEOAug 27, 2025AWARD361,200——Form 4
Zindrick ThomasPresident and CEOAug 27, 2025AWARD478,800$3.64$1.7MForm 4
Smalling RalphHead of RegulatoryAug 27, 2025AWARD26,230——Form 4
Smalling RalphHead of RegulatoryAug 27, 2025AWARD34,770$3.64$126.6KForm 4
Smither John WdirectorAug 27, 2025AWARD22,283——Form 4
Smither John WdirectorAug 27, 2025AWARD28,576$3.64$104.0KForm 4
Yu YongSVP, Clinical DevelopmentAug 27, 2025AWARD101,480——Form 4
Yu YongSVP, Clinical DevelopmentAug 27, 2025AWARD134,520$3.64$489.7KForm 4
Mirabelli MarydirectorAug 27, 2025AWARD22,283——Form 4
Mirabelli MarydirectorAug 27, 2025AWARD28,576$3.64$104.0KForm 4
Tyree James LdirectorAug 27, 2025AWARD22,283——Form 4
Tyree James LdirectorAug 27, 2025AWARD28,576$3.64$104.0KForm 4
Cappello JosephChief Technical OfficerAug 27, 2025AWARD107,500——Form 4
Cappello JosephChief Technical OfficerAug 27, 2025AWARD142,500$3.64$518.7KForm 4
Groen EricGeneral Counsel & SecretaryJul 1, 2025AWARD270,000$2.83$764.1KForm 4
Groen EricJul 1, 2025OTHER0——Form 4
Thomas JohndirectorJun 6, 2025GIFT25,000——Form 4
Ryder SeanGeneral CounselMay 12, 2025SELL4,475$2.92$13.1KForm 4
Zindrick Thomasdirector, officer: President and CEOMay 12, 2025SELL10,764$2.92$31.4KForm 4
Yu YongVP, Clinical Trial OperationsMay 12, 2025SELL5,579$2.92$16.3KForm 4
Cappello JosephVP, Pharmaceutical DevelopmentMay 12, 2025SELL4,737$2.92$13.8KForm 4
Smalling RalphHead of RegulatoryMay 12, 2025SELL1,259$2.92$3.7KForm 4
Smalling RalphHead of RegulatoryMar 14, 2025AWARD4,172——Form 4
Cappello JosephVP, Pharmaceutical DevelopmentMar 14, 2025AWARD13,350——Form 4
Yu YongVP, Clinical Trial OperationsMar 14, 2025AWARD13,350——Form 4
Ryder SeanGeneral CounselMar 14, 2025AWARD10,708——Form 4
Zindrick Thomasdirector, officer: President and CEOMar 14, 2025AWARD30,339——Form 4
Pulisic MatthewChief Financial OfficerJan 31, 2025AWARD275,000$3.95$1.1MForm 4
Pulisic MatthewJan 30, 2025OTHER0——Form 4
Thomas JohndirectorAug 1, 2024AWARD50,469$1.96$98.9KForm 4